🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "focused measures to tackle household expense challenges" in next month's Budget.

In comments to the BBC, she noted that curbing price rises is a joint responsibility of both the government and the Bank of England.

The United Kingdom's inflation rate is forecast to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Potential Energy Bill Interventions

It is understood the administration could take action to bring down energy bills, for instance by cutting the present 5% level of VAT charged on energy supplies.

Another approach is to reduce some of the regulatory levies currently included in bills.

Budgetary Constraints and Analyst Expectations

The administration will receive the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much room there is for such measures.

The consensus from the majority of experts is that the Chancellor will have to declare tax increases or spending cuts in order to adhere to her voluntary borrowing rules.

Previously on the same day, calculations suggested there was a twenty-two billion pound gap for the chancellor to fill, which is at the lower end of projections.

"It is a joint job between the Bank of England and the administration to continue tackling some of the sources of inflation," the Chancellor informed reporters in Washington, at the conferences of the IMF and World Bank.

Tax Pledges and International Issues

While a great deal of the focus has been on probable tax increases, the Treasury chief said the most recent figures from the OBR had not altered her pledge to manifesto promises not to increase tax levels on earnings tax, sales tax or National Insurance.

She blamed an "uncertain world" with rising international and commercial tensions for the fiscal revenue measures, probably to be targeted on those "with the broadest shoulders."

International Trade Disputes

Referring to apprehensions about the UK's trade ties with the Asian nation she said: "The UK's security interests always take priority."

Last week's announcement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led US President the US President to propose an additional 100% import tax on goods from the Asian country, increasing the possibility of an all-out commercial conflict between the two global powers.

The American finance chief described the Chinese decision "economic coercion" and "a international production control attempt."

Asked about considering the American proposal to participate in its dispute with China, Reeves said she was "extremely troubled" by Chinese measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the move was "harmful for the world economy and generates additional headwinds."

"It is my opinion there are sectors where we should address Chinese policies, but there are also valuable opportunities to export to China's economy, including financial services and other sectors of the economic system. We've got to get that equilibrium right."

The Treasury chief also affirmed she was collaborating with other major economies "regarding our own critical minerals plan, so that we are more independent."

Health Service Drug Costs and Investment

Reeves also acknowledged that the price the National Health Service pays for medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either halting or canceling projects in the UK, with some attributing the insufficient payments they are getting.

Recently, the Science Minister said the cost the NHS pays for drugs would have to rise to halt firms and pharmaceutical investment leaving the UK.

Reeves told the BBC: "We have seen due to the pricing regime, that medical research, recent pharmaceuticals have not been available in the UK in the manner that they are in other EU nations."

"We want to make sure that individuals receiving treatment from the NHS are can access the finest essential treatments in the globe. And so we are reviewing this situation, and... seeking to secure increased funding into Britain."